Substituted cyclopentanes having prostaglandin activity

Details for Australian Patent Application No. 2008331597 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2008331597

PCT Pub. Number WO2009/073432

Priority 60/991,003 29.11.07 US

Filing date 24 November 2008

Wipo publication date 11 June 2009

International Classifications

A61K 31/5575 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

C07D 333/40 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

17 June 2010 PCT application entered the National Phase

  PCT publication WO2009/073432 Priority application(s): WO2009/073432

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008331602-Polysaccharide gel formulation

2008331589-Process for promoting mercury retention in wet flue gas desulfurization systems